Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Genetic profile of Omicron subvariants in Vietnam by May 2024: The emergence of JN.1

Breadcrumb

  • Home
  • Genetic Profile of Omicron Subvariants In Vietnam By May 2024: The Emergence of JN.1
  • Genetic profile of Omicron subvariants in Vietnam by May 2024: The emergence of JN.1

Quan Ke Thai 1, * and Phuoc Huynh 2

1 Saigon University, 273 An Duong Vuong, Ward 3 District 5, Ho Chi Minh city, Vietnam, 700000.
2 VNU HCMC University of Science, 227 Nguyen Van Cu, Ward 4 District 5, Ho Chi Minh city, Vietnam, 700000.
Research Article
GSC Biological and Pharmaceutical Sciences, 2024, 27(03), 070–076.
Article DOI: 10.30574/gscbps.2024.27.3.0224
DOI url: https://doi.org/10.30574/gscbps.2024.27.3.0224
Received on 10 May 2024; revised on 08 June 2024; accepted on 10 June 2024
SARS-CoV-2 Omicron and its subvariants continue to significantly impact global infection and mortality rates. Omicron is characterized by its rapid transmissibility and its ability to evade immune defenses and neutralizing antibodies. The widespread prevalence of Omicron and its subvariants is attributed to mutations within the spike (S) gene. This study update the status of the nucleotide changes and genetic diversity of Omicron in Vietnam. Our analysis recorded new Omicron variants, including BA.2.86 and its descendant: BA.2.86.1; JN.1 and its descendants: JN.1.20, JN.1.4, JN.1.4.5, JN.1.11, and JN.1.16 since December of 2023. These newly found variants formed a separated group in the haplotype network. Our analysis identified five Omicron subvariants isolated in Vietnam: BA.1*, BA.2*, BA.4*, BA.5*, and XBB*. Among these, BA.2* exhibited the highest frequency and haplotype diversity index. We observed that mutations in the S gene predominantly occur in the S1 region, while the S2 region remains relatively conserved across Omicron subvariants.
This study provides a comprehensive analysis of the nucleotide alterations and genetic diversity of Omicron in Vietnam, confirming the critical role of the S gene in the evolution and control of SARS-CoV-2.
COVID-19; SARS-CoV-2; Spike gene; Genetic diversity; Omicron.
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2024-…

Preview Article PDF

Quan Ke Thai and Phuoc Huynh. Genetic profile of Omicron subvariants in Vietnam by May 2024: The emergence of JN.1. GSC Biological and Pharmaceutical Sciences, 2024, 27(3), 070-076. Article DOI: https://doi.org/10.30574/gscbps.2024.27.3.0224


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution